Zura Bio Limited
ZURA
$4.75
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 14.83% | -43.03% | 50.45% | 83.45% | 66.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.03% | 1.04% | 53.60% | 129.79% | 45.30% |
| Operating Income | -17.03% | -1.04% | -53.60% | -129.79% | -45.30% |
| Income Before Tax | -26.06% | 12.86% | -54.84% | -125.15% | -60.80% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -26.06% | 12.86% | -54.84% | -125.15% | -60.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.06% | 12.86% | -54.84% | -125.15% | -60.80% |
| EBIT | -17.03% | -1.04% | -53.60% | -129.79% | -45.30% |
| EBITDA | -16.97% | -0.98% | -53.51% | -- | -- |
| EPS Basic | -386.33% | 19.34% | -0.36% | -1,102.56% | 25.41% |
| Normalized Basic EPS | -20.94% | 19.51% | -23.11% | -13.66% | 16.87% |
| EPS Diluted | -386.33% | 19.34% | -0.36% | -1,102.56% | 25.41% |
| Normalized Diluted EPS | -20.94% | 19.51% | -23.11% | -13.66% | 16.87% |
| Average Basic Shares Outstanding | 4.25% | 8.28% | 25.81% | 98.16% | 93.31% |
| Average Diluted Shares Outstanding | 4.25% | 8.28% | 25.81% | 98.16% | 93.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |